The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2015

Filed:

Oct. 14, 2010
Applicants:

Jean-marc Combette, Saint-Cergues, FR;

Catherine Deloche, Geneva, CH;

Claire Abadie, Annecy, FR;

Inventors:

Jean-Marc Combette, Saint-Cergues, FR;

Catherine Deloche, Geneva, CH;

Claire Abadie, Annecy, FR;

Assignee:

Xigen Inflammation Ltd., Limassol, CY;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/04 (2006.01); C07K 14/00 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
C07K 14/001 (2013.01); A61K 38/005 (2013.01); A61K 38/1709 (2013.01);
Abstract

The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of non-chronic or chronic inflammatory eye diseases, such as inflammatory diseases of the blephara, conjunctiva, cornea, sclera, the vitreous body, uvea, ciliary body, choroid, orbital bone, lacrimal gland, or iris, in particular wherein the inflammatory disease is selected from hordeolum, chalazion, conjunktivitis, keratitis, scleritis, episcleritis, endophthalmitis, panophtalmitis, irititis, uveitis, cyclitis, chorioiditis, orbital phlegmon, and myositis of the eye muscle etc.


Find Patent Forward Citations

Combette, Jean-Marc. (2015). Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases (U.S. Patent No. 9150618). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9150618

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…